Interestingly, similar results were obtained with low-dose IL-6 treatment on chemotherapy-induced neuropathy models (70), highlighting that in addition to metabolic targets, IL-6 also exerts neuroprotective effects on nerve cells outside of the diabetic milieu. The gene discussed is IL6; the disease is neuropathy.